AUSTIN, Texas, Nov. 10, 2010 /PRNewswire/ — Luminex Corporation
LMNX) today announced that management will present at the
Stephens Fall Investment Conference to be held November 16-17,
2010, in New York.
The investor presentation by Patrick J. Balthrop, president and
chief executive officer, will begin at 8:30 a.m. Eastern time
on Wednesday, November 17, 2010. The presentation will
be webcast live and may be accessed at Luminex Corporation’s
website at http://www.luminexcorp.com.
Simply log on to the web at the address above, go to the
Company section and access the Investor Relations link.
Please go to the website at least 15 minutes prior to the
event to register, download and install any necessary audio/video
software. If you are unable to participate during the live webcast,
the presentation will be archived for six months on the website
using the ‘replay’ link.
Luminex Corporation develops, manufactures and markets
proprietary biological testing technologies with applications
throughout the diagnostic and life sciences industries. The
Company’s xMAP® multiplex solutions include an
open-architecture, multi-analyte technology platform that delivers
fast, accurate and cost-effective bioassay results to markets as
diverse as pharmaceutical drug discovery, clinical diagnostics and
biomedical research, including the genomics and proteomics research
markets. The Company’s xMAP technology is sold worldwide and
is already in use in leading clinical laboratories as well as major